Latent class analysis of bipolar disorder symptoms and suicidal ideation and behaviors.
Josephine S Au, Ana Martinez de Andino, Yara Mekawi...
https://pubmed.ncbi.nlm.nih.gov/32579284Actively Recruiting
Phase Not Applicable
Age: 18Years - 64Years
All Genders
ID02604277
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder: The Roles of Biological and Childhood and Adult Environmental Risk Factors
Led by Emory University · Updated on 2026-01-07
130
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the environmental and psychological factors that influence suicidal thoughts and behaviors in patients diagnosed with Bipolar Disorder. This study focuses on understanding why individuals with Bipolar Disorder have a high risk of suicide, exploring connections such as childhood maltreatment, impulsive aggression, and drug use. The research aims to improve suicide risk assessment and treatment, especially among low-income patients. Participants will take part in a 6-week group-based intervention program that includes therapies like Interpersonal and Social Rhythm Therapy, Bipolar-Specific Cognitive Behavioral Therapy, Mindfulness-Based Stress Reduction, and Psycho-education about Bipolar medications. Each therapy session lasts about 55-60 minutes and is conducted once a week in groups of 4 to 12 participants. During the study, participants will be evaluated using tools such as the Columbia-Suicide Severity Rating Scale before and after the intervention to measure changes in suicidal behavior. The study involves assessments of psychological and environmental factors, with the goal of reducing suicidal behaviors and improving quality of life. The total participation period is approximately six weeks, with monitoring focused on therapy effects and participant progress.
CONDITIONS
Brief Title
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Who Can Participate
Age: 18Years - 64Years
All Genders
Eligibility Criteria
You may qualify if you...
- English speaking
- Diagnosis of Bipolar Disorder (BD)
- Able to provide written informed consent
You will not qualify if you...
- Cognitive impairments
- Acutely psychotic
- Medically unstable
- History of schizophrenia spectrum disorder
- History of mood incongruent psychotic symptoms
- History of primary substance disorder
- History of primary organic disease and/or dementia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - 6 weeks
Participants receive group-based behavioral therapies including Interpersonal and Social Rhythm Therapy, Bipolar-Specific Cognitive Behavioral Therapy, Mindfulness-Based Stress Reduction, and Psycho-education & Understanding Bipolar Medications Therapy to reduce suicidal behavior and improve quality of life.
Weekly visits for therapy sessions
Trial Site Locations
Total: 1 location
1
Grady Health System
Atlanta, Georgia, United States, 30303
Actively Recruiting
Loading map...
Research Team
D
Dorian Lamis, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here